These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 17714607)

  • 1. Comparison of a step-down dose of once-daily ciclesonide with a continued dose of twice-daily fluticasone propionate in maintaining control of asthma.
    Knox A; Langan J; Martinot JB; Gruss C; Häfner D
    Curr Med Res Opin; 2007 Oct; 23(10):2387-94. PubMed ID: 17714607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM; Boulet LP; Follows RM
    Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of ciclesonide once daily and fluticasone propionate twice daily in children with asthma.
    Pedersen S; Engelstätter R; Weber HJ; Hirsch S; Barkai L; Emeryk A; Weber H; Vermeulen J
    Pulm Pharmacol Ther; 2009 Jun; 22(3):214-20. PubMed ID: 19141327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similar efficacy of ciclesonide once daily versus fluticasone propionate twice daily in patients with persistent asthma.
    Magnussen H; Hofman J; Staneta P; Lawo JP; Hellwig M; Engelstätter R
    J Asthma; 2007 Sep; 44(7):555-63. PubMed ID: 17885859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the efficacy of ciclesonide 160 microg QD and budesonide 200 microg BID in adults with persistent asthma: a phase III, randomized, double-dummy, open-label study.
    Niphadkar P; Jagannath K; Joshi JM; Awad N; Boss H; Hellbardt S; Gadgil DA
    Clin Ther; 2005 Nov; 27(11):1752-63. PubMed ID: 16368446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of twice-daily inhaled ciclesonide and fluticasone propionate in patients with moderate-to-severe persistent asthma.
    Bateman ED; Linnhof AE; Homik L; Freudensprung U; Smau L; Engelstätter R
    Pulm Pharmacol Ther; 2008; 21(2):264-75. PubMed ID: 17604664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 24-week comparison of low-dose ciclesonide and fluticasone propionate in mild to moderate asthma.
    Dahl R; Engelstätter R; Trebas-Pietraś E; Kuna P
    Respir Med; 2010 Aug; 104(8):1121-30. PubMed ID: 20430601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effect of low-dose ciclesonide and fixed-dose fluticasone propionate and salmeterol combination on long-term asthma control.
    Postma DS; O'Byrne PM; Pedersen S
    Chest; 2011 Feb; 139(2):311-318. PubMed ID: 21088114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of fluticasone furoate 100 μg once-daily in patients with persistent asthma: a 24-week placebo and active-controlled randomised trial.
    Lötvall J; Bleecker ER; Busse WW; O'Byrne PM; Woodcock A; Kerwin EM; Stone S; Forth R; Jacques L; Bateman ED
    Respir Med; 2014 Jan; 108(1):41-9. PubMed ID: 24295556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparable efficacy of ciclesonide once daily versus fluticasone propionate twice daily in asthma.
    Buhl R; Vinkler I; Magyar P; Györi Z; Rybacki C; Middle MV; Escher A; Engelstätter R
    Pulm Pharmacol Ther; 2006; 19(6):404-12. PubMed ID: 16310388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized comparison of ciclesonide 160 and 640 microg/day in severe asthma.
    Bateman ED; Cheung D; Lapa e Silva J; Göhring UM; Schäfer M; Engelstätter R
    Pulm Pharmacol Ther; 2008; 21(3):489-98. PubMed ID: 18178494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized study comparing ciclesonide and fluticasone propionate in patients with moderate persistent asthma.
    Boulet LP; Bateman ED; Voves R; Müller T; Wolf S; Engelstätter R
    Respir Med; 2007 Aug; 101(8):1677-86. PubMed ID: 17448650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacy and safety of ciclesonide 160 microg once daily vs. budesonide 400 microg once daily in children with asthma.
    von Berg A; Engelstätter R; Minic P; Sréckovic M; Garcia Garcia ML; Latoś T; Vermeulen JH; Leichtl S; Hellbardt S; Bethke TD
    Pediatr Allergy Immunol; 2007 Aug; 18(5):391-400. PubMed ID: 17617808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multinational, 12-week, randomized study comparing the efficacy and tolerability of ciclesonide and budesonide in patients with asthma.
    Hansel TT; Benezet O; Kafé H; Ponitz HH; Cheung D; Engelstätter R; Barnes PJ
    Clin Ther; 2006 Jun; 28(6):906-20. PubMed ID: 16860173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintaining asthma control in persistent asthma: comparison of three strategies in a 6-month double-blind randomised study.
    Godard P; Greillier P; Pigearias B; Nachbaur G; Desfougeres JL; Attali V
    Respir Med; 2008 Aug; 102(8):1124-31. PubMed ID: 18606533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety evaluation of ciclesonide in subjects with mild-to-moderate asthma not currently using inhaled corticosteroids.
    Berger WE; Kerwin E; Bernstein DI; Pedinoff A; Bensch G; Karafilidis J
    Allergy Asthma Proc; 2009; 30(3):304-14. PubMed ID: 19549432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ciclesonide and fluticasone on cortisol secretion in patients with persistent asthma.
    Derom E; Louis R; Tiesler C; Engelstätter R; Kaufman JM; Joos GF
    Eur Respir J; 2009 Jun; 33(6):1277-86. PubMed ID: 19164356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma.
    Aalbers R; Backer V; Kava TT; Omenaas ER; Sandström T; Jorup C; Welte T
    Curr Med Res Opin; 2004; 20(2):225-40. PubMed ID: 15006018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroid-sparing effects of fluticasone propionate 100 microg and salmeterol 50 microg administered twice daily in a single product in patients previously controlled with fluticasone propionate 250 microg administered twice daily.
    Busse W; Koenig SM; Oppenheimer J; Sahn SA; Yancey SW; Reilly D; Edwards LD; Dorinsky PM
    J Allergy Clin Immunol; 2003 Jan; 111(1):57-65. PubMed ID: 12532097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.